WADA to launch independent review into Chinese doping case

The under-fire World Anti-Doping Agency (WADA) said on Thursday it would launch an independent review over its handling of a case that allowed 23 Chinese swimmers who tested positive for a banned substance to avoid punishment.

The investigation will be led by Swiss prosecutor Eric Cottier, a former attorney general of the canton of Vaud, who WADA said will have access to all files and documents related to the case and will be free to consult any independent experts.

Cottier will begin his work in the coming days and is expected to deliver his findings within two months.

"WADA'ss integrity and reputation is under attack," said WADA president Witold Banka in a statement.

"In the past few days, WADA has been unfairly accused of bias in favour of China by not appealing the CHINADA case to the Court of Arbitration for Sport," he said referring to China's anti-doping agency and sport's highest court respectively.

"We continue to reject the false accusations and we are pleased to be able to put these questions into the hands of an experienced, respected and independent prosecutor."

Calls for an independent investigation have grown since a New York Times report on Saturday said 23 Chinese swimmers had tested positive for the banned drug trimetazidine (TMZ) months before the COVID-delayed Tokyo Olympics in July 2021.

The swimmers avoided sanctions after an investigation by Chinese authorities ruled the adverse analytical findings, or AAFs, were the result of being inadvertently exposed to the drug through contamination.

A report determined all the swimmers who tested positive were staying at the same hotel where traces of trimetazidine (TMZ), which is found in heart medication, were discovered in the kitchen.

WADA has defended